Andrew A. Hindman
2020
In 2020, Andrew A. Hindman earned a total compensation of $2.1M as Senior Vice President and Chief Financial Officer at Theravance Biopharma, a 44% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $265,278 |
|---|---|
| Salary | $551,608 |
| Stock Awards | $1,275,144 |
| Other | $5,920 |
| Total | $2,097,950 |
Hindman received $1.3M in stock awards, accounting for 61% of the total pay in 2020.
Hindman also received $265.3K in non-equity incentive plan, $551.6K in salary and $5.9K in other compensation.
Rankings
In 2020, Andrew A. Hindman's compensation ranked 5,300th out of 13,090 executives tracked by ExecPay. In other words, Hindman earned more than 59.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,300 out of 13,090 | 60th |
Division Manufacturing | 2,180 out of 5,620 | 61st |
Major group Chemicals And Allied Products | 871 out of 2,253 | 61st |
Industry group Drugs | 750 out of 1,953 | 62nd |
Industry Pharmaceutical Preparations | 561 out of 1,458 | 62nd |
Pay ratio
| Andrew A. Hindman's Pay | $2,097,950 |
|---|---|
| Median Employee's Pay | $269,883 |
| Pay Ratio | 8to 1 |
In 2020, the annual total compensation of Andrew A. Hindman was $2,097,950.
The annual total compensation of the median employee at Theravance Biopharma was $269,883.
The ratio of Andrew A. Hindman's pay to the pay of median employee was therefore 8 to one.
Source: SEC filing on March 22, 2021.
Hindman's colleagues
We found four more compensation records of executives who worked with Andrew A. Hindman at Theravance Biopharma in 2020.